VANCOUVER, BRITISH COLUMBIA--(Marketwire - November 17, 2008) - Perceptronix Medical Inc. will be exhibiting at the St. Paul's Hospital Annual Continuing Medical Education Conference from November 18 - 21. Perceptronix will be showcasing LungSign™, an innovative early lung cancer test currently available for lung cancer risk assessment, as well as premiering an instructional video demonstrating its use. The company will be exhibiting at booth 127 at the Vancouver Convention & Exhibition Centre.
